In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp
- PMID: 15328085
- PMCID: PMC514744
- DOI: 10.1128/AAC.48.9.3279-3283.2004
In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp
Abstract
Caspofungin (CAS) inhibits fungal cell wall synthesis. Sulfamethoxazole (SMX) inhibits folate biosynthesis and is active in vitro against Aspergillus spp. We studied the activities of the combination of CAS and SMX against 31 Aspergillus isolates and compared them with that of SMX combined with amphotericin B (AMB) or itraconazole (ITC). MICs and minimal effective concentrations (MECs) were determined by the NCCLS broth microdilution method. With MIC endpoints, the combination of SMX and CAS showed synergy or synergy to additivity against 29 of 31 isolates. With MEC endpoints, synergy to additivity was found against 12 of 31 isolates and indifference was displayed against the rest of them. SMX in combination with AMB or ITC was not truly synergistic, while synergy to additivity was found for SMX-AMB and SMX-ITC against 17 of 31 and 3 of 12 isolates, respectively. No antagonism was found with any of the drug combinations. Further analysis of the synergy of CAS and SMX was performed by detailed measurement of hyphal length by microscopy and time-dependent 2,3-bis(2-methoxy-4-nitro-5-[(sulfenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT)-based hyphal damage experiments. With MEC endpoints, the combination of CAS and SMX was characterized by a greater than 50% decrease in hyphal length compared to the hyphal lengths achieved with double the concentration of each drug alone. The XTT-based hyphal damage studies showed a statistically significant (P < 0.05) reduction in viability with CAS and SMX in combination compared to the viabilities achieved with double the concentration of each drug alone. These findings support the synergy results found by using MIC endpoints and suggest that visual MEC measurements may not be sufficient to identify the synergistic interactions seen by more sensitive, quantitative methods. Animal models are required to validate the significance of the synergy of CAS and SMX against Aspergillus spp. observed in vitro.
Figures


Similar articles
-
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.Antimicrob Agents Chemother. 2003 Apr;47(4):1416-8. doi: 10.1128/AAC.47.4.1416-1418.2003. Antimicrob Agents Chemother. 2003. PMID: 12654681 Free PMC article.
-
Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.J Clin Microbiol. 2001 Dec;39(12):4256-63. doi: 10.1128/JCM.39.12.4256-4263.2001. J Clin Microbiol. 2001. PMID: 11724829 Free PMC article.
-
Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.J Clin Microbiol. 2005 Aug;43(8):3788-92. doi: 10.1128/JCM.43.8.3788-3792.2005. J Clin Microbiol. 2005. PMID: 16081911 Free PMC article.
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
-
[In vitro activity of the echinocandins. How should it be evaluated?].Rev Iberoam Micol. 2005 Sep;22(3):133-40. doi: 10.1016/s1130-1406(05)70026-7. Rev Iberoam Micol. 2005. PMID: 16309347 Review. Spanish.
Cited by
-
Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs.Antimicrob Agents Chemother. 2018 Feb 23;62(3):e00701-17. doi: 10.1128/AAC.00701-17. Print 2018 Mar. Antimicrob Agents Chemother. 2018. PMID: 29263071 Free PMC article.
-
Riboflavin and pantothenic acid biosynthesis are crucial for iron homeostasis and virulence in the pathogenic mold Aspergillus fumigatus.Virulence. 2018;9(1):1036-1049. doi: 10.1080/21505594.2018.1482181. Virulence. 2018. PMID: 30052132 Free PMC article.
-
Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.Antimicrob Agents Chemother. 2007 Mar;51(3):881-7. doi: 10.1128/AAC.01160-06. Epub 2006 Dec 4. Antimicrob Agents Chemother. 2007. PMID: 17145783 Free PMC article.
-
In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum.Antimicrob Agents Chemother. 2010 Sep;54(9):3978-9. doi: 10.1128/AAC.00793-10. Epub 2010 Jun 21. Antimicrob Agents Chemother. 2010. PMID: 20566767 Free PMC article.
-
Comparison of echinocandin antifungals.Ther Clin Risk Manag. 2007 Mar;3(1):71-97. doi: 10.2147/tcrm.2007.3.1.71. Ther Clin Risk Manag. 2007. PMID: 18360617 Free PMC article.
References
-
- Afeltra, J., J. F. Meis, J. W. Mouton, and P. E. Verweij. 2001. Prevention of invasive aspergillosis in AIDS by sulfamethoxazole. AIDS 15:1067-1068. - PubMed
-
- Bayley, A. M., and I. G. Macreadie. 2002. Folic acid antagonism of sulfa drug treatments. Trends Parasitol. 18:49-50. - PubMed
-
- Brown, J. S., A. Aufauvre-Brown, J. Brown, J. M. Jennings, H. J. Arst, and D. W. Holden. 2000. Signature-tagged and directed mutageneses identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity. Mol. Microbiol. 36:1371-1380. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous